"We are committed to providing the highest quality and the most compassionate care."

During the past decade, Retreat Cardiology LLC, dba Cardiology Associates of Richmond conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Retreat Cardiology LLC, dba Cardiology Associates of Richmond" are "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Retreat Cardiology LLC, dba Cardiology Associates of Richmond" in a lesser frequency.

Most popular intervention types in "Retreat Cardiology LLC, dba Cardiology Associates of Richmond" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retreat Cardiology LLC, dba Cardiology Associates of Richmond" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Retreat Cardiology LLC, dba Cardiology Associates of Richmond". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Retreat Cardiology LLC, dba Cardiology Associates of Richmond, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Retreat Cardiology LLC, dba Cardiology Associates of Richmond, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".